MétaCan
Menu
Back to cohort
Record W2143602377 · doi:10.1038/sj.bjc.6605416

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

2009· article· en· W2143602377 on OpenAlexafffund
Ana Osório, Roger L. Milne, Guillermo Pita, Paolo Peterlongo, Tuomas Heikkinen, Jacques Simard, Georgia Chenevix‐Trench, Amanda B. Spurdle, Jonathan Beesley, X. Chen, Sue Healey, Susan L. Neuhausen, Yuan Chun Ding, Fergus J. Couch, X. Wang, Noralane M. Lindor, Siranoush Manoukian, Monica Barile, Alessandra Viel, Laura Tizzoni, Csilla I. Szabo, Lenka Foretová, Michal Zikán, Kathleen Claes, Mark H. Greene, PL Mai, Gad Rennert, Flavio Lejbkowicz, Ofra Barnett‐Griness, Irene L. Andrulis, H Ozçelik, Nayana Weerasooriya, Mads Thomassen, D. G. Crüger, Maria A. Caligo, Eitan Friedman, Bella Kaufman, Yael Laitman, S. I. Cohen, Tair Kontorovich, Ruth Gershoni‐Baruch, Efrat Dagan, Helena Jernström, Marie Stenmark Askmalm, Brita Arver, Beatrice Malmer, Susan M. Domchek, Katherine L. Nathanson, Joan Brunet, Teresa Ramón y Cajal, Drakoulis Yannoukakos, Ute Hamann, Frans B.L. Hogervorst, Senno Verhoef, E. Gómez, Juul Wijnen, A. van den Ouweland, Douglas F. Easton, S. Peock, Mark Cook, Clare T Oliver, D Frost, Craig Luccarini, D. Gareth Evans, Fiona Lalloo, Rosalind A. Eeles, Gabriella Pichert, Jackie Cook, Shirley Hodgson, Patrick J. Morrison, Gillian Douglas, Andrew K. Godwin, Olga M. Sinilnikova, Laure Barjhoux, Dominique Stoppa‐Lyonnet, Virginie Moncoutier, Sophie Giraud, Carina Cassini, Laurence Olivier-Faivre, Françoise Révillion, J-P Peyrat, D Müller, J-P Fricker, Henry T. Lynch, Esther M. John, Saundra S. Buys, Mary B. Daly, John L. Hopper, Mary Beth Terry, Alexander Miron, Yosuf Yassin, David E. Goldgar, Christian F. Singer, Daphne Gschwantler‐Kaulich, Georg Pfeiler, A.-C. Spiess, Thomas van Overeem Hansen, Oskar T. Johannsson, Tomas Kirchhoff, Kenneth Offit, Kristi Kosarin, Marion Piedmonte, Gustavo C. Rodriguez, Katie Wakeley, John F. Boggess, Jack Basil, Peter E. Schwartz, Stephanie V. Blank, Amanda E. Toland, Marco Montagna, Cinzia Casella, Evgeny N. Imyanitov, Anna Allavena, Rita K. Schmutzler, Beatrix Versmold, Christoph Engel, A Meindl, Nina Ditsch, Norbert Arnold, Dieter Niederacher, Heidrun L. Deissler, Britta Fiebig, Raymonda Varon-Mateeva, D Schaefer, Ursula G. Froster, Trinidad Caldés, Miguel de la Hoya, Lesley McGuffog, Antonis C. Antoniou, Heli Nevanlinna, Paolo Radice, Javier Benı́tez

Bibliographic record

VenueBritish Journal of Cancer · 2009
Typearticle
Languageen
FieldBiochemistry, Genetics and Molecular Biology
TopicBRCA gene mutations in cancer
Canadian institutionsCancer Care OntarioMount Sinai HospitalUniversité LavalLunenfeld-Tanenbaum Research InstituteCentre hospitalier universitaire de Québec
FundersNational Cancer InstituteNational Health and Medical Research CouncilNational Institutes of HealthFondazione Italiana per la Ricerca sul CancroUniversità degli Studi di TorinoRadboud Universitair Medisch CentrumDeutsche KrebshilfeMedical Research Councillékařská fakulta Univerzity KarlovyLeids Universitair Medisch CentrumAssociazione Italiana per la Ricerca sul CancroOdense UniversitetshospitalLunds UniversitetVlaamse regeringSahlgrenska UniversitetssjukhusetErasmus Medisch CentrumVrije Universiteit AmsterdamUniversiteit LeidenAarhus UniversitetshospitalNational Institute for Health and Care ResearchRussian Foundation for Basic ResearchKWF KankerbestrijdingCancer Research UKUniversité LavalRoyal Marsden NHS Foundation TrustCompagnia di San PaoloHuntsman Cancer InstituteNational Breast Cancer FoundationBreast Cancer Research FoundationIstituto Oncologico VenetoAarhus UniversitetUniverzita Karlova v PrazeAlleanza Contro il CancroUppsala UniversitetMinistero dell’Istruzione, dell’Università e della RicercaMemorial Sloan-Kettering Cancer CenterInstituto de Salud Carlos IIIRadboud UniversiteitOhio State UniversityCanadian Institutes of Health ResearchFonds Wetenschappelijk OnderzoekUniversiteit GentUniversity of PennsylvaniaMinistero della SaluteAkademiska SjukhusetCancer Care Ontario
KeywordsBreast cancerOncologyMedicineBRCA mutationSNPInternal medicineAllelePopulationMutationCancerBRCA2 ProteinGenotypeGeneticsBiologySingle-nucleotide polymorphismGermline mutationGene

Abstract

fetched live from OpenAlex

BACKGROUND: In this study we aimed to evaluate the role of a SNP in intron 1 of the ERCC4 gene (rs744154), previously reported to be associated with a reduced risk of breast cancer in the general population, as a breast cancer risk modifier in BRCA1 and BRCA2 mutation carriers. METHODS: We have genotyped rs744154 in 9408 BRCA1 and 5632 BRCA2 mutation carriers from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) and assessed its association with breast cancer risk using a retrospective weighted cohort approach. RESULTS: We found no evidence of association with breast cancer risk for BRCA1 (per-allele HR: 0.98, 95% CI: 0.93-1.04, P = 0.5) or BRCA2 (per-allele HR: 0.97, 95% CI: 0.89-1.06, P = 0.5) mutation carriers. CONCLUSION: This SNP is not a significant modifier of breast cancer risk for mutation carriers, though weak associations cannot be ruled out.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.004
metaresearch head score (Gemma)0.007
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.004
Threshold uncertainty score0.019

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0040.007
Meta-epidemiology (narrow)0.0010.000
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0000.000
Scholarly communication0.0010.000
Open science0.0010.000
Research integrity0.0010.000
Insufficient payload (model declined to judge)0.0020.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.018
GPT teacher head0.304
Teacher spread0.285 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations14
Published2009
Admission routes2
Has abstractyes

Explore more

Same venueBritish Journal of CancerSame topicBRCA gene mutations in cancerFrench-language works237,207